Meet the PI

Elisabeth D. Martinez, Ph.D.

Elisabeth D. Martinez, Ph.D.

  • Associate Professor, Department of Pharmacology and Hamon Center for Therapeutic Oncology Research
  • Associate Director of Cancer Center Culture, Harold C. Simmons Comprehensive Cancer Center

"In my laboratory, I seek to empower trainees with conceptual, experimental and life-long skills and habits that will enable them to be responsible contributors to the scientific world and to society, while building a positive environment that welcomes individuals from all backgrounds. I have been blessed with teams which included trainees and junior faculty with varied experiences and out-of-the-box career paths who have enriched our work and our lives.”

Research Interests

  • Deregulation of transcriptional pathways in cancer
  • Drug discovery
  • Epigenetic control of gene expression
  • Novel therapeutics for gene expression disorders including cancer
  • The role of Jumonji histone demethylases in cancer
  • Transcriptional regulation by nuclear receptors

Positions

2022 – present: Associate Director of Diversity, Equity and Inclusion, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas

2019 – present: Associate Professor (with tenure), Department of Pharmacology, University of Texas Southwestern Medical Center at Dallas

2013 – 2019: Assistant Professor (Tenure-accruing Track), Department of Pharmacology, University of Texas Southwestern Medical Center at Dallas

2009 – 2013: Assistant Professor (Research Track), Department of Pharmacology, University of Texas Southwestern Medical Center at Dallas

2005 – 2009: Instructor, Department of Pharmacology, University of Texas Southwestern Medical Center at Dallas

2002 – 2005: Postdoctoral Fellow, Laboratory of Receptor Biology and Gene Expression National Cancer Institute, NIH, Bethesda, Md. Supervisor: Gordon L. Hager, Ph.D.

1996 – 2002: Graduate Student Research Fellow, Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, D.C. Supervisor/mentor: Mark Danielsen, Ph.D.

1994 – 1996: Research Assistant, Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, D.C. Supervisor: Mark Danielsen, Ph.D.

1993 – 1994: Undergraduate Research Assistant, Department of Chemistry, Boston College, Newton, Mass. Supervisor: Mary Roberts, Ph.D.

Education

Georgetown University (2002)

Honors and Awards

  • 2019: The John P. Perkins Distinguished Professorship in Biomedical Science
  • 2018: SWAT teaching award nomination, UTSW Cancer Biology Program
  • 2018: Named ‘Top twelve women innovators at UT Southwestern”, Office of Technology Transfer, UTSW
  • 2016: Gilman Special Opportunities Award, UTSW Department of Pharmacology
  • 2015: Friends of the Cancer Center Award, UTSW
  • 2013: Dean’s LEAD Program Capstone Recognition Award, UTSW
  • 2013: Early Investigator Abstract Award, Keystone Symposia
  • 2007: Abstract Award, International Association for the Study of Lung Cancer
  • 2006: Travel Award, EMBO (09/06)
  • 2004: Technology Transfer Award, National Institutes of Health
  • 2003: FARE Research Excellence Award, National Institutes of Health
  • 2002: Travel Award, Keystone Symposia (02/02)
  • 2000: Travel Awards, Women in Endocrinology (06/00), Graduate Student Organization (07/00)
  • 1994: Phi Beta Kappa – Boston College Chapter

Professional Societies/Affiliations

  • 1995-2002: Nuclear Receptor Resource Project, Co-founder and member
  • 1997-2007: Endocrine Society, member
  • 1997-2007: Women in Endocrinology, member
  • 2002-2005: National Postdoctoral Association, member
  • 2003-2005: Women in Science Think Tank, Founder
  • 2004-2006: American Society for Cell Biology, member
  • 2006-present: American Association for Cancer Research, active member
  • 2007-present: Simmons Comprehensive Cancer Center, member UTSW
  • 2009-2013: Molecular Therapeutics of Cancer Faculty, member UTSW
  • 2013-present: Experimental Therapeutics Faculty, UTSW
  • 2013-present: Co-leader of Molecular Therapeutic Sensitizers theme, SCCC, UTSW
  • 2014-present: American Chemical Society, member
  • 2022-present: DEI Forum, NCCN